UA89408C2 - Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof - Google Patents

Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof

Info

Publication number
UA89408C2
UA89408C2 UAA200714180A UAA200714180A UA89408C2 UA 89408 C2 UA89408 C2 UA 89408C2 UA A200714180 A UAA200714180 A UA A200714180A UA A200714180 A UAA200714180 A UA A200714180A UA 89408 C2 UA89408 C2 UA 89408C2
Authority
UA
Ukraine
Prior art keywords
trimethoxybenzyl
pharmaceutical composition
sustained release
piperazine
solid pharmaceutical
Prior art date
Application number
UAA200714180A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Жером Бессе
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA89408C2 publication Critical patent/UA89408C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Abstract

The inventive sustained release solid pharmaceutical composition comprises an 1-(2,3,4-trimethoxybenzyl) piperazine active substance or the pharmaceutically acceptable salt thereof combined with at least one type of polyethylene oxide, at least one type of lubricating agent and one or several pharmaceutically acceptable excipients.
UAA200714180A 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof UA89408C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (en) 2005-05-18 2005-05-18 SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD

Publications (1)

Publication Number Publication Date
UA89408C2 true UA89408C2 (en) 2010-01-25

Family

ID=35583424

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200714180A UA89408C2 (en) 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof

Country Status (5)

Country Link
EP (1) EP1881831A1 (en)
EA (1) EA013645B1 (en)
FR (1) FR2885807B1 (en)
UA (1) UA89408C2 (en)
WO (1) WO2006123073A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0815602A2 (en) * 2007-08-08 2015-03-03 Usv Ltd PROPOSED TRIMETHYZIDINE RELEASE COMPOSITIONS AND PROCESS FOR PREPARING THEM
WO2009034541A2 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
EP2389167A2 (en) * 2009-01-20 2011-11-30 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
TR201001902A2 (en) * 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
US20110274751A1 (en) * 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717687B1 (en) * 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.
FR2802424B1 (en) * 1999-12-17 2002-02-15 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
ATE442852T1 (en) * 2000-10-05 2009-10-15 Usv Ltd DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
FR2818549B1 (en) * 2000-12-26 2003-02-07 Servier Lab SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF TRIMETAZIDINE
EP1448173A2 (en) * 2001-11-21 2004-08-25 Themis Laboratories Private Limited A process for manufacture of a sustained release pharmaceutical composition containing microbeads of trimetazidine dihydrochloride

Also Published As

Publication number Publication date
WO2006123073A1 (en) 2006-11-23
FR2885807B1 (en) 2008-05-16
FR2885807A1 (en) 2006-11-24
EP1881831A1 (en) 2008-01-30
EA200702386A1 (en) 2008-04-28
EA013645B1 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
UA88477C2 (en) Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
MX2007002189A (en) Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery.
TW200609005A (en) Film-coated tablet with plural coating-layers
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
EP1993567A4 (en) Orally administrable gallium compositions and method of use
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
TW200640487A (en) Combination of XOLAIR with immunosuppressive agent
ME00207B (en) Composition comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent
ZA200603538B (en) P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
PL1906916T3 (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
BG108516A (en) Pharmaceutical formulation
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
UA89408C2 (en) Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
WO2005007137A8 (en) Tablets containing ambroxol
MXPA03008420A (en) Solid orally-dispersible pharmaceutical formulation.
BR0112847A (en) Use of a solid dosage form
EP3949967A8 (en) Solid pharmaceutical composition comprising tlr7 agonist
TW200509980A (en) Parasiticidal composition
WO2007121471A3 (en) Dialkyl ether delivery agents
TW200621304A (en) Pharmaceutical composition
PT1499278E (en) IMMEDIATE RELEASE PHARMACEUTICAL FORM FOR COMPOSITION OF TIBOLONE POLYMER
GR1004331B (en) New pharmaceutical compositions that contain a salt of alendronic acid.
MY158344A (en) Oral drug delivery system
EP1842556A4 (en) Therapeutic agent for attention-deficit hyperactivity disorder